.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Queensland Health
Chubb
Harvard Business School
QuintilesIMS
UBS
Colorcon
Julphar
Deloitte
Chinese Patent Office

Generated: November 22, 2017

DrugPatentWatch Database Preview

Actavis Labs Company Profile

« Back to Dashboard

What is the competitive landscape for ACTAVIS LABS, and what generic and branded alternatives to ACTAVIS LABS drugs are available?

ACTAVIS LABS has one hundred and six approved drugs.

There are three tentative approvals on ACTAVIS LABS drugs.

Summary for Actavis Labs

US Patents:0
Tradenames:82
Ingredients:73
NDAs:106
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Labs Fl Inc
DILTIAZEM HYDROCHLORIDE
diltiazem hydrochloride
TABLET, EXTENDED RELEASE;ORAL077686-001Mar 15, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
Actavis Labs Fl Inc
ALPRAZOLAM
alprazolam
TABLET, EXTENDED RELEASE;ORAL077198-002May 13, 2010DISCNNoNo► Subscribe► Subscribe► Subscribe
Actavis Labs Ut Inc
LOXITANE
loxapine succinate
TABLET;ORAL017525-006Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Actavis Labs Ut Inc
TESTOSTERONE
testosterone
GEL;TRANSDERMAL076737-002Jan 27, 2006AB1RXNoNo► Subscribe► Subscribe► Subscribe
Actavis Labs Ut Inc
CLONIDINE
clonidine
FILM, EXTENDED RELEASE;TRANSDERMAL090873-003May 6, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
Actavis Labs Fl Inc
TAZTIA XT
diltiazem hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL075401-001Apr 10, 2003AB4RXNoNo► Subscribe► Subscribe► Subscribe
Actavis Labs Fl Inc
PALIPERIDONE
paliperidone
TABLET, EXTENDED RELEASE;ORAL202645-004Aug 3, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Actavis Labs Ut Inc
LOXITANE
loxapine succinate
CAPSULE;ORAL017525-002Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Actavis Labs Fl Inc
RISPERIDONE
risperidone
TABLET, ORALLY DISINTEGRATING;ORAL076996-005Apr 19, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
Actavis Labs Fl Inc
DICLOFENAC SODIUM AND MISOPROSTOL
diclofenac sodium; misoprostol
TABLET, DELAYED RELEASE;ORAL201089-002Jul 9, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Actavis Labs

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Actavis Labs Ut Inc
LOXITANE
loxapine succinate
CAPSULE;ORAL017525-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Actavis Labs Ut Inc
LOXITANE
loxapine succinate
CAPSULE;ORAL017525-004Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Actavis Labs Ut Inc
LOXITANE IM
loxapine hydrochloride
INJECTABLE;INJECTION018039-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Actavis Labs Ut Inc
LOXITANE C
loxapine hydrochloride
CONCENTRATE;ORAL017658-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Actavis Labs Ut Inc
EMLA
lidocaine; prilocaine
CREAM;TOPICAL019941-001Dec 30, 1992► Subscribe► Subscribe
Actavis Labs Ut Inc
LOXITANE C
loxapine hydrochloride
CONCENTRATE;ORAL017658-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Actavis Labs Ut Inc
EMLA
lidocaine; prilocaine
CREAM;TOPICAL019941-001Dec 30, 1992► Subscribe► Subscribe
Actavis Labs Ut Inc
LOXITANE
loxapine succinate
CAPSULE;ORAL017525-003Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Actavis Labs Ut Inc
LOXITANE
loxapine succinate
CAPSULE;ORAL017525-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for ACTAVIS LABS drugs

Drugname Dosage Strength Tradename Submissiondate
omeprazole
Delayed-release Tablets20 mg
OMEPRAZOLE
6/3/2015

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Chubb
Boehringer Ingelheim
Chinese Patent Office
Queensland Health
Fuji
Express Scripts
Daiichi Sankyo
Farmers Insurance
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot